Will emerging prostate cancer markers redeem themselves?
Hotakainen
Kristina
K
Department of Clinical Chemistry, University of Helsinki and Helsinki University Central Hospital, Biomedicum Helsinki, Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
Stenman
Ulf-Håkan
UH
D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D006801:Humans; D008297:Male; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; C479341:prostate cancer antigen 3, human; D017430:Prostate-Specific Antigen